Assessment of Health-Related Quality of Life in Patients With Overactive Bladder Taking Tolterodine Extended Release Versus Placebo
Khullar V1, Hill S 2, Solanki J3 1. Imperial College, School of Medicine, 2. Queen's Park Hospital, 3. Pfizer, Inc
| Abstract 318 |
| Non Discussion Posters Scientific Non Discussion Poster Session 17 |
|